From: HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Characteristics | Â | HOTAIR RNA expression | ||
---|---|---|---|---|
Negative | Positive | P valuea | ||
(n = 62) | (n = 72) | |||
Age | Â | Â | Â | 0.166 |
  ≤ 62.7 years (median age) | 67 | 35 | 32 |  |
  > 62.7 years (median age) | 67 | 27 | 40 |  |
FIGO stage | Â | Â | Â | 0.733 |
 I/II | 37 | 18 | 19 |  |
 III/IV | 97 | 44 | 53 |  |
Tumour grade | Â | Â | Â | 0.182 |
 I/II | 78 | 33 | 45 |  |
 III | 51 | 28 | 23 |  |
 Unknown | 5 | 1 | 4 |  |
Histology | Â | Â | Â | 0.145 |
 Serous cancer | 56 | 28 | 28 |  |
 Mucinous cancer | 43 | 19 | 24 |  |
 Endometrioid cancer | 24 | 14 | 10 |  |
 Clear cell cancer | 6 | 1 | 5 |  |
 Not classifiable ovarian tissue | 2 | 0 | 2 |  |
 Fallopian tube cancer | 3 | 0 | 3 |  |
Residual disease after surgery | Â | Â | Â | 0.308 |
 No residual disease | 46 | 22 | 24 |  |
 Residual disease ≤ 2 cm | 36 | 19 | 17 |  |
 Residual disease > 2 cm | 45 | 20 | 25 |  |
 Unknown | 7 | 1 | 6 |  |
Chemotherapy | Â | Â | Â | 0.453 |
 Not performed | 16 | 6 | 10 |  |
 Performed | 118 | 56 | 62 |  |
Health status | Â | Â | Â | 0.074 |
 No relapse | 56 | 31 | 25 |  |
 Relapse | 78 | 31 | 47 |  |
Survival status | Â | Â | Â | 0.023 |
 Alive | 39 | 24 | 15 |  |
 Dead | 95 | 38 | 57 |  |